Charles Ramassamy Selected Research

Polyphenols

1/2021	Polyphenol-Peptide Interactions in Mitigation of Alzheimer's Disease: Role of Biosurface-Induced Aggregation.
1/2016	Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State.
1/2015	Innovative Anthocyanin/Anthocyanidin Formulation Protects SK-N-SH Cells Against the Amyloid-β Peptide-Induced Toxicity: Relevance to Alzheimer's Disease.
7/2008	Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles Ramassamy Research Topics

Disease

28	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 07/2007
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2010
6	Cognitive Dysfunction 01/2021 - 01/2010
6	Neuroblastoma 01/2017 - 12/2006
2	Dementia (Dementias) 01/2021 - 01/2021
2	Chronic Disease (Chronic Diseases) 01/2015 - 07/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2014 - 01/2010
2	Wounds and Injuries (Trauma) 04/2014 - 06/2003
1	Brain Diseases (Brain Disorder) 12/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020
1	Body Weight (Weight, Body) 12/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Amyloidosis 01/2019
1	Mental Disorders (Mental Disorder) 04/2014
1	Brain Ischemia (Cerebral Ischemia) 04/2014
1	Atrophy 03/2013
1	Neuroinflammatory Diseases 11/2011
1	Rhinitis 05/2010
1	Cough 05/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2008
1	Neoplasms (Cancer) 07/2008
1	Diabetes Mellitus 09/2007

Drug/Important Bio-Agent (IBA)

11	Acrolein (Aqualin)IBA 01/2017 - 01/2010
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2003
6	Peptides (Polypeptides)IBA 01/2021 - 12/2006
5	Amyloid (Amyloid Fibrils)IBA 12/2020 - 11/2011
4	PolyphenolsIBA 01/2021 - 07/2008
4	Pharmaceutical PreparationsIBA 12/2020 - 06/2011
4	Therapeutic UsesIBA 12/2020 - 09/2010
3	AntioxidantsIBA 01/2021 - 12/2020
3	CurcuminIBA 02/2016 - 11/2011
2	ApolipoproteinsIBA 01/2021 - 01/2021
2	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2021
2	Anthocyanins (Anthocyanin)IBA 12/2020 - 01/2015
2	Ginkgo biloba extract (Rokan)IBA 07/2007 - 12/2006
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Neuroprotective AgentsIBA 12/2020
1	Vanillic AcidIBA 12/2020
1	protocatechuic acidIBA 12/2020
1	AcidsIBA 12/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	Advanced Glycation End ProductsIBA 01/2019
1	Claudin-5IBA 01/2019
1	pentosidineIBA 01/2019
1	OccludinIBA 01/2019
1	CytokinesIBA 01/2019
1	BerberineIBA 02/2015
1	LithiumIBA 04/2014
1	AldehydesIBA 04/2014
1	homocysteic acidIBA 10/2013
1	Blood Proteins (Serum Proteins)IBA 06/2011
1	AshwagandhaIBA 09/2010
1	Plant ExtractsIBA 09/2010
1	GuanosineIBA 06/2010
1	PolymersIBA 05/2010
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2010
1	NeuroprostanesIBA 01/2010
1	LipidsIBA 01/2010
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2010
1	Caspase 3 (Caspase-3)IBA 01/2010
1	NF-kappa B (NF-kB)IBA 12/2006
1	FlavonoidsIBA 12/2006
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2003
1	Estrogen Receptor betaIBA 06/2003

Therapy/Procedure

2	Therapeutics 11/2011 - 09/2007
1	Oral Administration 12/2020